{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:14:26Z","timestamp":1793319266318,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302301"],"award-info":[{"award-number":["82302301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.canlet.2025.217930","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:50:25Z","timestamp":1752623425000},"page":"217930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Multimodal radiopathomics signature for prediction of response to immunotherapy-based combination therapy in gastric cancer using interpretable machine learning"],"prefix":"10.1016","volume":"631","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8046-1151","authenticated-orcid":false,"given":"Weicai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rou","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangneng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9824-0170","authenticated-orcid":false,"given":"Qing","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Edward","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Tauhidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9797-7106","authenticated-orcid":false,"given":"M. Usman","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiongqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3442-754X","authenticated-orcid":false,"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2025.217930_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.canlet.2025.217930_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00428-015-1734-7","article-title":"Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: a longitudinal study from 1980 to 2010 with data from cancer registry Zurich","volume":"466","author":"Bieri","year":"2015","journal-title":"Virchows Arch."},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12885-015-1081-8","article-title":"Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin \u2013 a longitudinal experience from a prospectively collected database of 1108 patients","volume":"15","author":"Seyfried","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2025.217930_bib4","article-title":"Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study","volume":"10","author":"Jiang","year":"2022"},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2135819","article-title":"Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer","volume":"11","author":"Tang","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2025.217930_bib6","article-title":"Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: a single-arm, open-label, phase II trial","volume":"12","author":"Guo","year":"2022","journal-title":"Front. Oncol."},{"issue":"10294","key":"10.1016\/j.canlet.2025.217930_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (checkMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.canlet.2025.217930_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0013","article-title":"Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial","volume":"4","author":"Fuchs","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2025.217930_bib9","article-title":"Evaluation of neoadjuvant immunotherapy in resectable gastric\/gastroesophageal junction tumors: a meta-analysis and systematic review","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217930_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.08.2296","article-title":"LBA6_PR nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer\/gastroesophageal junction cancer (GC\/GEJC)\/esophageal adenocarcinoma (EAC): first results of the CheckMate 649 study","volume":"31","author":"Moehler","year":"2020","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217930_bib11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1158\/2159-8290.CD-20-1312","article-title":"Paradigms on immunotherapy combinations with chemotherapy","volume":"11","author":"Salas-Benito","year":"2021","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.canlet.2025.217930_bib12","article-title":"Clinical efficacy of immunotherapy combined with chemotherapy in patients with advanced gastric cancer, its effect on nutritional status and changes of peripheral blood T lymphocyte subsets: treatment on patients with advanced gastric cancer","volume":"37","author":"Li","year":"2021","journal-title":"Pakistan J. Med. Sci."},{"issue":"3","key":"10.1016\/j.canlet.2025.217930_bib13","article-title":"Society for immunotherapy of cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy","volume":"11","author":"Naiyer","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2025.217930_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217930_bib15","article-title":"PD-L1 is prognostic and a negative predictor of response to immunotherapy in gastric cancer","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.canlet.2025.217930_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1470-2045(22)00783-5","article-title":"Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study","volume":"24","author":"Wang","year":"2023","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2025.217930_bib17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrclinonc.2017.88","article-title":"Monitoring immune-checkpoint blockade: response evaluation and biomarker development","volume":"14","author":"Nishino","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217930_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","article-title":"Cancer associated-fibroblast-derived exosomes in cancer progression","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2025.217930_bib20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ccell.2022.09.012","article-title":"Artificial intelligence for multimodal data integration in oncology","volume":"40","author":"Lipkova","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217930_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101080","article-title":"Circumventing drug resistance in gastric cancer: a spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics","volume":"74","author":"Che","year":"2024","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib22","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2589-7500(21)00215-6","article-title":"Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study","volume":"4","author":"Feng","year":"2022","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.canlet.2025.217930_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.03.295","article-title":"Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer","author":"Jiang","year":"2020","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib24","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1038\/s41467-022-34703-w","article-title":"Prognostic and predictive value of a pathomics signature in gastric cancer","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.canlet.2025.217930_bib25","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/S2589-7500(22)00024-3","article-title":"Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study","volume":"4","author":"Wang","year":"2022","journal-title":"Lancet Digit. Health"},{"issue":"22","key":"10.1016\/j.canlet.2025.217930_bib26","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.2017.14585","article-title":"Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer","volume":"318","author":"Ehteshami","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.canlet.2025.217930_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1470-2045(23)00061-X","article-title":"Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study","volume":"24","author":"Wu","year":"2023","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2025.217930_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007807","article-title":"Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter study","volume":"11","author":"Huang","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2025.217930_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008927","article-title":"Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer","volume":"12","author":"Han","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat. Mach. Intell."},{"issue":"14","key":"10.1016\/j.canlet.2025.217930_bib31","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1158\/1078-0432.CCR-13-0895","article-title":"Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements","volume":"19","author":"Nishino","year":"2013","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"issue":"7","key":"10.1016\/j.canlet.2025.217930_bib32","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker","year":"2003","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.canlet.2025.217930_bib33","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1109\/TPAMI.2005.159","article-title":"Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy","volume":"27","author":"Hanchuan","year":"2005","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"10.1016\/j.canlet.2025.217930_bib34","series-title":"Proceedings of the 31st International Conference on Neural Information Processing Systems","first-page":"4768","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017"},{"issue":"3","key":"10.1016\/j.canlet.2025.217930_bib35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.canlet.2025.217930_bib36","article-title":"Evaluation of neoadjuvant immunotherapy plus chemotherapy in Chinese surgically resectable gastric cancer: a pilot study by meta-analysis","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217930_bib37","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.22.02331","article-title":"Immunotherapy and targeted therapy for advanced gastroesophageal cancer: ASCO guideline","volume":"41","author":"Shah","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41467-023-44309-5","article-title":"Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial","volume":"15","author":"Lin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217930_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.959295","article-title":"Neoadjuvant tislelizumab and tegafur\/gimeracil\/octeracil (S-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: early results of a phase 2, single-arm trial","volume":"12","author":"Yin","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217930_bib40","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41591-023-02721-w","article-title":"Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial","volume":"30","author":"Yuan","year":"2024","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.canlet.2025.217930_bib41","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1245\/s10434-023-13143-w","article-title":"Neoadjuvant therapy with immune checkpoint inhibitors in gastric cancer: a systematic review and meta-analysis","volume":"30","author":"Li","year":"2023","journal-title":"Ann. Surg Oncol."},{"issue":"4_suppl","key":"10.1016\/j.canlet.2025.217930_bib42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1200\/JCO.2023.41.4_suppl.364","article-title":"PERSIST: a multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric\/gastroesophageal junction cancer (GC\/GEJC)","volume":"41","author":"Ding","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217930_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100379","article-title":"Prediction of prognostic risk factors in hepatocellular carcinoma with transarterial chemoembolization using multi-modal multi-task deep learning","volume":"23","author":"Liu","year":"2020","journal-title":"eClinicalMedicine"},{"issue":"10","key":"10.1016\/j.canlet.2025.217930_bib44","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s43018-022-00416-8","article-title":"Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer","volume":"3","author":"Vanguri","year":"2022","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib45","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1038\/s41467-024-53450-8","article-title":"An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer","volume":"15","author":"Gao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217930_bib46","unstructured":"Huang YQ, Chen XB, Cui YF, Yang F, Huang SX, Li ZH, et al. Enhanced risk stratification for stage II colorectal cancer using deep learning-based CT classifier and pathological markers to optimize adjuvant therapy decision. Ann. Oncol..."},{"key":"10.1016\/j.canlet.2025.217930_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217557","article-title":"Multimodal radiopathological integration for prognosis and prediction of adjuvant chemotherapy benefit in resectable lung adenocarcinoma: a multicentre study","volume":"616","author":"Lin","year":"2025","journal-title":"Cancer Lett."},{"issue":"15","key":"10.1016\/j.canlet.2025.217930_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202411490","article-title":"Multimodal artificial intelligence-based virtual biopsy for diagnosing abdominal lavage cytology-positive gastric cancer","volume":"12","author":"Ding","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41597-023-02032-2","article-title":"Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer","volume":"10","author":"Zhao","year":"2023","journal-title":"Sci. Data"},{"issue":"1","key":"10.1016\/j.canlet.2025.217930_bib51","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1038\/s41467-022-32816-w","article-title":"Noninvasive imaging of the tumor immune microenvironment correlates with response to immunotherapy in gastric cancer","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217930_bib52","article-title":"Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from 18F fluorodeoxyglucose PET\/CT images in gastric cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.canlet.2025.217930_bib53","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41571-019-0252-y","article-title":"Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology","volume":"16","author":"Bera","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217930_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/23808993.2019.1585805","article-title":"Deep learning and radiomics in precision medicine","volume":"4","author":"Parekh","year":"2019","journal-title":"Expert Rev. Precis. Med. Drug Dev."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525004999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525004999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:20:07Z","timestamp":1772742007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525004999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":54,"alternative-id":["S0304383525004999"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217930","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal radiopathomics signature for prediction of response to immunotherapy-based combination therapy in gastric cancer using interpretable machine learning","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217930"}}